1999
Recruitment in AIDS Clinical Trials: Investigation of Sociodemographic and Psychosocial Factors Affecting Participation in Clinical Research
Ethier K, Rodriguez M, Fox-Tierney R, Martin C, Friedland G, Ickovics J. Recruitment in AIDS Clinical Trials: Investigation of Sociodemographic and Psychosocial Factors Affecting Participation in Clinical Research. AIDS And Behavior 1999, 3: 219-230. DOI: 10.1023/a:1025456527845.Peer-Reviewed Original ResearchTrial participantsIDU historyClinical trialsAIDS clinical trialsGroup of HIVTrial regimenMedical therapyPsychosocial factorsHIV therapeuticsClinical researchTrial resultsTrialsBehavioral factorsHIVSociodemographic dimensionsPrimary objectiveParticipantsNonparticipantsRegimenPatientsTherapyMSMSociodemographicsRecruitmentPotential Sex Differences Remain Understudied: A Case Study of the Inclusion of Women in HIV/AIDS-Related Neuropsychological Research
Fox-Tierney R, Ickovics J, Cerreta C, Ethier K. Potential Sex Differences Remain Understudied: A Case Study of the Inclusion of Women in HIV/AIDS-Related Neuropsychological Research. Review Of General Psychology 1999, 3: 44-54. DOI: 10.1037/1089-2680.3.1.44.Peer-Reviewed Original ResearchSex differencesQuality of studiesHIV/AIDSPopulation of personsPotential sex differencesNeuropsychological manifestationsClinical researchMore womenWomenHIVNeuropsychological researchComprehensive literature reviewLiterature reviewInclusion of womenComplicationsReliable sex differencesStudyAIDSDifferences
1997
Adherence in AIDS clinical trials: A framework for clinical research and clinical care
Ickovics J, Meisler A. Adherence in AIDS clinical trials: A framework for clinical research and clinical care. Journal Of Clinical Epidemiology 1997, 50: 385-391. PMID: 9179096, DOI: 10.1016/s0895-4356(97)00041-3.Peer-Reviewed Original ResearchConceptsClinical trialsAIDS clinical trialsPoor medication adherenceAssessment of adherencePatient-provider relationshipClinical trial dataProtease inhibitor drugsTreatment regimenMedication adherenceMedical adherencePatient participationClinical careDrug failureTherapeutic outcomesViral resistanceNew treatmentsPatient careTrial dataTherapeutic valueClinical settingClinical interventionsClinical researchInhibitor drugsTrialsGood adherence
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply